Exercise of Warrants

In brief · summary, not quotable

Alkemy Capital Investments PLC announced the exercise of 20,000 warrants at £2.00 each, resulting in proceeds of £40,000 for the company. Consequently, Alkemy will issue 20,000 new ordinary shares. Application has been made for these new shares to be admitted to trading on the London Stock Exchange, with admission expected on November 7, 2025. Following admission, the company's enlarged share capital will consist of 9,966,865 ordinary shares. This figure is relevant for shareholders calculating their notification requirements regarding their interest in the company under FCA rules.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your ALK notes

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received notice to exercise 20,000 warrants of £2.00 each that were granted to investors in the placing as announced on 17 February 2025, resulting in the receipt of £40,000. The Company will accordingly issue 20,000 new ordinary shares of the Company (the "New Ordinary Shares").

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 7 November 2025 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 9,966,865 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.